Proven technology leader to play key role at fast-growing pharmaceutical services firm
|
|||||
PRINCETON, N.J., March 14, 2016 -- APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Ms. Aparna Mazumdar has joined the firm as Head of Global Business Solutions. Aparna will lead the development and implementation of technology-based solutions for APCER’s expanding offices and rapidly growing client base.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4061d734-3a14-471e-b850-b6d3287f548f
“We are taking major steps to enhance our information technology and business solutions through significant investments in talent, processes, and assets,” said Suneet Walia, President and CEO of APCER Life Sciences, Inc. “We are pleased to welcome Aparna, a proven technology leader in the pharmaceutical industry, to play a key role in the next phase of our journey.”
Aparna has more than fifteen years’ experience in managing IT organizations and executing enterprise level projects. She worked for twelve years at Sun Pharma in positions of increasing responsibility and was most recently the Global Head of R&D IT at Sun Pharmaceutical Industries Ltd. Prior to that, Aparna worked with Pentasoft Technologies Ltd. as Project Manager & Faculty. She also has three years of research experience.
“APCER has a bold plan to develop products and services that maximize efficiencies and compliance,” said Aparna Mazumdar. “I’m excited to apply the experience I’ve gained inside a dynamic pharmaceutical company to deliver solutions that will provide benefits across the global marketplace.”
Aparna holds a Master of Life Sciences degree from DAVV Indore, a Master of Biotechnology and Engineering from India Institute of Technology Kharagpur, one of India’s most prestigious technical universities, and a Master of Business Administration with specialization in Strategic Management and Information Technology from Management Development Institute, a premier business school in Gurgaon, India.
Aparna will be based in APCER’s Delhi, India office and lead a global team located in Delhi and London, UK.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with its clients. It brings together safety, medical, regulatory, and technology resources from around the world to ensure that patients receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health, please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com; and contact APCER at one of their global offices.
Jill Notte APCER Life Sciences 609-436-4714


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Instagram Outage Disrupts Thousands of U.S. Users
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



